Skip to main content
. 2016 Sep 13;14(1):244. doi: 10.1186/s12957-016-0999-x

Fig. 1.

Fig. 1

a Overall survivals of ER- or PR-negative group and ER- and PR-positive group in the luminal B HER-2 negative breast cancer (p = 0.0119). b Disease-free survivals of ER- or PR-negative group and ER- and PR-positive group in the luminal B HER-2-negative breast cancer (p = 0.0338). c Overall survivals of PR-positive, PR low, and PR-negative group in the luminal B HER-2-negative breast cancer (p < 0.0001). d Disease-free survivals of PR-positive, PR low, and PR-negative group in the luminal B HER-2-negative breast cancer (p = 0.0005) (Additional file 1)